argenx SE
ARGX · NASDAQ · Healthcare
- Solid growthRevenue growth (FY): 89.6%
- Analysts broadly positive90-day rating revisions: 1↑ / 0↓
- Healthy balance sheetAltman Z-Score: 20.57
Valuation may be demandingDCF upside: -668.4%


Explore stocks
Pick a curated list, or browse every company we cover. Each stock shows its Quant Score with the strengths and risks behind it, in plain English.
Profitable businesses with strong returns on capital
Reasonable prices relative to earnings and cash flow
Steady revenue growth and rising profits, year after year
Companies paying meaningful dividends from solid finances
Fast-growing sales and earnings
Healthy balance sheets and solid financial scores
Share prices in a healthy uptrend
The biggest companies with the best overall scores
The highest overall scores in our coverage
Source: Financial Modeling Prep · 724 companies covered · data as of Oct 24, 2026
ARGX · NASDAQ · Healthcare
Valuation may be demandingDCF upside: -668.4%
ONC · NASDAQ · Healthcare
Valuation may be demandingDCF upside: -1062.0%
ALPMY · OTC · Healthcare
Weakest area: analyst viewAnalyst buy share: 67%
REGN · NASDAQ · Healthcare
Weakest area: growth potentialRevenue growth (FY): 1.0%
LLY · NYSE · Healthcare
Valuation may be demandingDCF upside: -43.2%
DXCM · NASDAQ · Healthcare
Weakest area: valuationDCF upside: -52.4%
ALNY · NASDAQ · Healthcare
Valuation may be demandingDCF upside: -735.5%
BSX · NYSE · Healthcare
Weakest area: risk profileLargest 1Y drawdown: -60%
BLLN · NASDAQ · Healthcare
Profitability is thinReturn on invested capital (TTM): 6.3%
MDT · NYSE · Healthcare
Growth is slow or negativeRevenue CAGR (3Y): 5.2%
MCK · NYSE · Healthcare
Growth is slow or negativeGross margin: 3.6%
RMD · NYSE · Healthcare
Growth is slow or negativeForward revenue growth: 2.9%
VRTX · NASDAQ · Healthcare
Weakest area: valuationDCF upside: -35.5%
TAK · NYSE · Healthcare
Profitability is thinReturn on equity (TTM): 2.4%
CI · NYSE · Healthcare
Profitability is thinOperating margin (TTM): 3.5%
BMXXY · OTC · Healthcare
Growth is slow or negativeNet income growth (FY): -11.7%
BBNX · NASDAQ · Healthcare
Valuation may be demandingP/E (TTM): -11.4x
JNJ · NYSE · Healthcare
Analysts are cautiousTarget upside: 8.1%
ABT · NYSE · Healthcare
Growth is slow or negativeNet income growth (FY): -51.3%
HUM · NYSE · Healthcare
Profitability is thinOperating margin (TTM): 1.4%
ATEC · NASDAQ · Healthcare
Profitability is thinReturn on equity (TTM): -819.0%
EW · NYSE · Healthcare
Valuation may be demandingDCF upside: -38.0%
COR · NYSE · Healthcare
Growth is slow or negativeGross margin: 3.7%
SNY · NASDAQ · Healthcare
Profitability is thinReturn on equity (TTM): 5.5%
BMY · NYSE · Healthcare
Analysts are cautiousAnalyst buy share: 45%
ALBBY · OTC · Healthcare
Shares can be volatilePrice volatility (1Y, annualised): 80%
ALHC · NASDAQ · Healthcare
Profitability is thinOperating margin (TTM): 1.2%
ELV · NYSE · Healthcare
Growth is slow or negativeForward revenue growth: 0.3%
GSK · NYSE · Healthcare
Analysts are cautiousAnalyst buy share: 31%
DHR · NYSE · Healthcare
Growth is slow or negativeRevenue CAGR (3Y): -2.7%
AZN · NYSE · Healthcare
Analysts are cautiousAnalyst buy share: 49%
SYK · NYSE · Healthcare
Analysts are cautious90-day rating revisions: 0↑ / 1↓
ISRG · NASDAQ · Healthcare
Valuation may be demandingDCF upside: -72.5%
AMGN · NASDAQ · Healthcare
Analysts are cautious90-day rating revisions: 0↑ / 2↓
CAH · NYSE · Healthcare
Growth is slow or negativeGross margin: 3.8%
IDXX · NASDAQ · Healthcare
Valuation may be demandingDCF upside: -70.4%
CNC · NYSE · Healthcare
Growth is slow or negativeNet income growth (FY): -301.9%
NVS · NYSE · Healthcare
Analysts are cautiousAnalyst buy share: 24%
BIIB · NASDAQ · Healthcare
Growth is slow or negativeNet income growth (FY): -20.8%
RDY · NYSE · Healthcare
Profitability is thinReturn on invested capital (TTM): 5.8%
ABBV · NYSE · Healthcare
Growth is slow or negativeRevenue CAGR (3Y): 1.8%
CVS · NYSE · Healthcare
Growth is slow or negativeNet income growth (FY): -61.7%
CNMD · NYSE · Healthcare
Analysts are cautiousTarget upside: -23.9%
HLN · NYSE · Healthcare
Growth is slow or negativeRevenue CAGR (3Y): 0.5%
A · NYSE · Healthcare
Growth is slow or negativeRevenue CAGR (3Y): 0.5%
NVO · NYSE · Healthcare
Analysts are cautious90-day rating revisions: 0↑ / 1↓
BIO · NYSE · Healthcare
Profitability is thinReturn on equity (TTM): 3.2%
NTRA · NASDAQ · Healthcare
Valuation may be demandingP/E (TTM): -298.2x
HCA · NYSE · Healthcare
Growth is slow or negativeForward revenue growth: 3.8%
TEM · NASDAQ · Healthcare
Valuation may be demandingP/E (TTM): -46.9x
UNH · NYSE · Healthcare
Growth is slow or negativeNet income growth (FY): -16.3%
ARWR · NASDAQ · Healthcare
Profitability is thinReturn on equity (TTM): -60.5%
MRK · NYSE · Healthcare
Profitability is thinReturn on equity (TTM): 6.6%
GILD · NASDAQ · Healthcare
Profitability is thinReturn on equity (TTM): -16.3%
ILMN · NASDAQ · Healthcare
Valuation may be demandingDCF upside: -120.0%
GEHC · NASDAQ · Healthcare
Growth is slow or negativeRevenue CAGR (3Y): 4.0%
CERT · NASDAQ · Healthcare
Analysts are cautiousTarget upside: -17.7%
ALC · NYSE · Healthcare
Profitability is thinReturn on equity (TTM): 2.9%
PFE · NYSE · Healthcare
Growth is slow or negativeRevenue CAGR (3Y): -14.8%
WAT · NYSE · Healthcare
Valuation may be demandingP/E (TTM): 112.4x
BDX · NYSE · Healthcare
Profitability is thinReturn on equity (TTM): 3.8%
TMO · NYSE · Healthcare
Growth is slow or negativeRevenue CAGR (3Y): -0.3%
IONS · NASDAQ · Healthcare
Profitability is thinReturn on equity (TTM): -110.8%
IQV · NYSE · Healthcare
Growth is slow or negativeGross margin: 26.2%
BAX · NYSE · Healthcare
Profitability is thinReturn on equity (TTM): -16.6%
BDSX · NASDAQ · Healthcare
Balance sheet is stretchedAltman Z-Score: -5.43
RVMD · NASDAQ · Healthcare
Growth is slow or negativeNet income growth (FY): -88.5%
AMRX · NASDAQ · Healthcare
Profitability is thinNet margin (TTM): 5.0%
ELAN · NYSE · Healthcare
Profitability is thinReturn on equity (TTM): -3.0%
TEVA · NYSE · Healthcare
Balance sheet is stretchedAltman Z-Score: 0.90
BAYRY · OTC · Healthcare
Profitability is thinReturn on equity (TTM): -6.1%
MRNA · NASDAQ · Healthcare
Valuation may be demandingP/E (TTM): -28.4x